# Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria

> **NCT01636895** · PHASE4 · UNKNOWN · sponsor: **Malaria Consortium, UK** · enrollment: 600 (estimated)

## Conditions studied

- Pregnancy Complications Parasitic

## Interventions

- **DRUG:** Efficacy of suphladoxine/pyrimethamine as IPTp
- **DRUG:** Efficacy of suphladoxine/pyrimethamine as IPTp

## Key facts

- **NCT ID:** NCT01636895
- **Lead sponsor:** Malaria Consortium, UK
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-11
- **Final completion:** 2013-02
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2012-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01636895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01636895, "Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01636895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*